Tumorigenesis in mice carrying a truncating Brca1 mutation

Genes and Development

Volumn 15, Issue 10, 2001, Pages 1188-1193

  Ludwig, Thomas ^a   Fisher, Peter ^b   Ganesan, Shridar ^c   Efstratiadis, Argiris ^a,b  

^a Dept of Anat and Cell Biology ^*  (United States)

^b Columbia University ^*  (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Brca1; Mammary tumors; Mouse mutant

Indexed keywords

BRCA1 PROTEIN; GENE PRODUCT; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MUTATION; GENE TARGETING; HISTOPATHOLOGY; LYMPHOMA; MALE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; STOCHASTIC MODEL;

ANIMALS; BLOTTING, NORTHERN; BRCA1 PROTEIN; FEMALE; LYMPHOMA; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; MUTAGENESIS; NEOPLASMS, EXPERIMENTAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, EXPERIMENTAL; SEQUENCE DELETION;

ANIMALIA;

EID: 0035872860     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.879201     Document Type: Article

References (15)

1. Attardi, L.D. and Jacks, T. 1999. The role of p53 in tumour suppression: Lessons from mouse models. Cell. Mol. Life Sci. 55: 48-63.
2. Boyd, M., Harris, F., McFarlane, R., Davidson, H.R., and Black, D.M. 1995. A human BRCA1 gene knockout. Nature 375: 541-542.
3. Cardiff, R.D., Anver, M.R., Gusterson, B.A., Hennighausen, L., Jensen, R.A., Merino, M.J., Rehm, S., Russo, J., Tavassoli, F.A., Wakefield, L.M., et al. 2000. The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting. Oncogene 19: 968-988.
4. Cressman, V.L., Backlund, D.C., Avrutskaya, A.V., Leadon, S.A., Godfrey, V., and Koller, B.H. 1999. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol. Cell. Biol. 19: 7061-7075.
5. Deng, C.-X. and Scott, F. 2000. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation. Oncogene 19: 1059-1064.
6. Dunn, T.B. 1959. Morphology of mammary tumors in mice. In The physiopathology of cancer. (ed. F. Homburger), pp. 38-84. Hoeber-Harper, New York.
7. Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023.
8. Harvey, M., McArthur, M.J., Montgomery, C.A., Bradley, A., and Donehower, L.A. 1993. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7: 938-943.
9. Medina, D. 1996. Preneoplasia in mammary tumorigenesis. In Mammary tumor cell cycle, differentiation, and metastasis. (eds. R.B. Dickson and M.E. Lippman), pp. 37-69. Kluwer Academic Publishers, Boston.
10. Medina, D., Butel, J.S., Socher, S.H., and Miller, F.L. 1980. Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL × DBA/2f F1 mice. Cancer Res. 40: 368-373.
11. Mixon, M., Kittrell, F., and Medina, D. 2000. Expression of Brca1 and splice variant Brca1Δ11 RNA levels in mouse mammary gland during normal development and tumorigenesis. Oncogene 19: 5237-5243.
12. Monteiro, A.N. 2000. BRCA1: Exploring the links to transcription. Trends Biochem. Sci. 25: 469-474.
13. Scully, R. and Livingston, D.M. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429-432.
14. Welcsh, P.L., Owens, K.N., and King, M.C. 2000. Insights into the functions of BRCA1 and BRCA2. Trends Genet. 16: 69-74.
15. Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., and Deng, C.-X. 1999. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22: 37-43.